跳至主要内容
临床试验/NCT02758548
NCT02758548已完成2 期

A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement Using a Novel Point of Care Test Device Compared to a Reference Method in Atopic Subjects

Novartis Pharmaceuticals13 个研究点 分布在 5 个国家目标入组 193 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
193
试验地点
13
主要终点
Total IgE concentration

研究概览

简要总结

The purpose of this study is to determine the accuracy of the Novel point of care test (POCT) total IgE assay in atopic patients.

120 patients with atopic conditions and approximately 40 healthy subjects will be enrolled. Fingerstick capillary blood samples will be collected and tested in the POCT device. Venous samples will be collected and sent to a reference laboratory for measurement of serum total IgE using the reference immunoassay method.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Total IgE concentration

时间窗: Day 0 or Day 1 (Visit 2: Blood sampling)

Total IgE concentration in capillary blood measured with the POCT device at Day 0 or Day 1 from enrollment. Total IgE concentration in venous blood measured with the reference method at Day 0 or Day 1 from enrollment.

次要结局

  • Device usability questionnaire response(Day 0 or Day 1 (Visit 2: Blood sampling))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验